Miconazole 3

Manufacturer
Walgreen Company
Effective date
2018-10-04
Label type
HUMAN OTC DRUG LABEL
Version
5
Source
legacy-cache
Hydrated at
2026-08-02 00:49:33

Label at a glance#

ProductMiconazole 3
Active ingredientMICONAZOLE NITRATE
Label structure10 sections

Indications and uses

• treats vaginal yeast infections • relieves external itching and irritation due to a vaginal yeast infection

Dosage and administration

• before using this product read the enclosed consumer information leaflet for complete directions and information • adults and children 12 years of age and over: • applicators: insert 1 applicatorful into the vagina at bedtime for 3 nights in a row. Throw applicator away after use. • external cream: squeeze a small amount of cream onto your fingertip. Apply the cream onto the itchy, irritated skin outside the vag...

Storage and handling

• do not use if printed applicator wrapper is torn, open, or incompletely sealed • do not use if seal over tube opening has been punctured • do not purchase if carton is open • store at 20°-25°C (68°-77°F)

Label contents#

Full prescribing information#

Active ingredients

OTC - ACTIVE INGREDIENT SECTION

Miconazole nitrate 4% (200 mg in each applicator)

Miconazole nitrate 2% (external cream)

Purpose

OTC - PURPOSE SECTION

Vaginal antifungal

Uses

INDICATIONS & USAGE SECTION

  • treats vaginal yeast infections
  • relieves external itching and irritation due to a vaginal yeast infection

Warnings

WARNINGS SECTION

For vaginal use only

Do not use

OTC - DO NOT USE SECTION

if you have never had a vaginal yeast infection diagnosed by a doctor

Ask a doctor before use if you have

OTC - ASK DOCTOR SECTION

  • vaginal itching and discomfort for the first time
  • lower abdominal, back or shoulder pain, fever, chills, nausea, vomiting, or foul-smelling vaginal discharge. You may have a more serious condition.
  • vaginal yeast infections often (such as once a month or 3 in 6 months). You could be pregnant or have a serious underlying medical cause for your symptoms, including diabetes or a weakened immune system.
  • been exposed to the human immunodeficiency virus (HIV) that causes AIDS

Ask a doctor or pharmacist before use if you are

OTC - ASK DOCTOR/PHARMACIST SECTION

taking the prescription blood thinning medicine warfarin, because bleeding or bruising may occur

When using this product

OTC - WHEN USING SECTION

  • do not use tampons, douches, spermicides or other vaginal products. Condoms and diaphragms may be damaged and fail to prevent pregnancy or sexually transmitted diseases (STDs).
  • do not have vaginal intercourse
  • mild increase in vaginal burning, itching or irritation may occur
  • if you do not get complete relief ask a doctor before using another product

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • symptoms do not get better in 3 days
  • symptoms last more than 7 days
  • you get a rash or hives, abdominal pain, fever, chills, nausea, vomiting, or foul-smelling vaginal discharge

If pregnant or breast-feeding,

OTC - PREGNANCY OR BREAST FEEDING SECTION

ask a health professional before use.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away (1-800-222-1222).

Directions

DOSAGE & ADMINISTRATION SECTION

  • before using this product read the enclosed consumer information leaflet for complete directions and information
  • adults and children 12 years of age and over:
  • applicators: insert 1 applicatorful into the vagina at bedtime for 3 nights in a row. Throw applicator away after use.
  • external cream: squeeze a small amount of cream onto your fingertip. Apply the cream onto the itchy, irritated skin outside the vagina (vulva). Use 2 times daily for up to 7 days, as needed.
  • children under 12 years of age: ask a doctor

Other information

STORAGE AND HANDLING SECTION

  • do not use if printed applicator wrapper is torn, open, or incompletely sealed
  • do not use if seal over tube opening has been punctured
  • do not purchase if carton is open
  • store at 20°-25°C (68°-77°F)

Inactive ingredients

INACTIVE INGREDIENT SECTION

  • Prefilled applicators: benzoic acid, cetyl alcohol, isopropyl myristate, polysorbate 60, potassium hydroxide, propylene glycol, purified water, stearyl alcohol
  • External cream: benzoic acid, butylated hydroxyanisole, glyceryl stearate, mineral oil, peglicol 5 oleate, pegoxol 7 stearate, purified water

Questions or comments?

OTC - QUESTIONS SECTION

1-800-719-9260

Consumer Information

SPL UNCLASSIFIED SECTION

3-Day Treatment

Miconazole Nitrate Vaginal Cream (4%) and Miconazole Nitrate Cream (2%)

VAGINAL ANTIFUNGAL

COMBINATION PACK

Cures Most Vaginal Yeast Infections and Relieves Associated External Itching and Irritation

Why should I use this product?

This product contains 3 cream prefilled applicators that cure most vaginal yeast infections, plus an external cream that can be used for relief of itching and irritation on the skin outside the vagina (vulva) due to a yeast infection. Do not use this product if this is the first time you have vaginal discharge, itching, burning and discomfort. See your doctor or health professional first to find out the cause of your symptoms. If a doctor has told you in the past that you had a vaginal yeast infection and you have the same symptoms now (such as vaginal discharge, itching or burning), then this product may work for you.

What is a vaginal yeast infection?

A vaginal yeast infection is a common condition caused by an overgrowth of yeast (Candida) that may normally live in the vagina. Your doctor may call this infection "monilia" or "candidiasis." Some women may have a yeast infection on the skin outside of the vagina (vulva) at the same time that they have a vaginal infection.

Who can get a vaginal yeast infection?

You can get a vaginal yeast infection at any age. It is most common during the childbearing years. Women who are pregnant or diabetic, taking antibiotics, birth control pills or steroids, or who have a weakened immune system are more likely to get repeated yeast infections that may not clear up easily with proper treatment.

Some medical conditions can weaken the body's normal ability to fight infection. One of the most serious of these conditions is infection with the human immunodeficiency virus (HIV - the virus that causes AIDS). The HIV virus causes the body to be more likely to get infections, including vaginal yeast infections that may not clear up easily with proper treatment. If you may have been exposed to HIV and get repeated vaginal yeast infections, you should see your doctor right away. For more information on HIV infection, please contact your doctor or the CDC National AIDS HOTLINE. The CDC phone numbers are:

1-800-232-4636 (English/Spanish), or 1-888-232-6348 (hearing impaired, TTY).

How can I tell if I have a vaginal yeast infection?

When you have a vaginal yeast infection, you may have one or more of the following symptoms:

  • vaginal itching
  • vaginal discharge that may be thick, white, and lumpy like cottage cheese
  • vaginal soreness, irritation, or burning
  • rash or redness on the skin outside the vagina (vulva)
  • burning on urination
  • painful vaginal intercourse (sex)

Note: Vaginal yeast infections do NOT cause fever, chills, lower abdominal, back or shoulder pain, foul-smelling vaginal discharge, or a missed period. These may be signs of a sexually transmitted disease (STD) or a tubal pregnancy. If you have these symptoms, call your doctor right away.

What are other causes of a vaginal discharge?

It is normal to have a small amount of vaginal discharge at certain times of the month. This normal discharge may be clear or slightly white and does not cause itching, pain or a foul odor.

The most common cause of an abnormal vaginal discharge is an infection. These infections include bacterial vaginosis (BV), trichomoniasis (Trich), gonorrhea (GC) and/or chlamydia. All of these may be transmitted sexually and are called sexually transmitted diseases (STDs). If you have more questions about sexually transmitted diseases (STDs) call the CDC Hotline at 1-800-232-4636.

Although many of the infections mentioned above can cause symptoms similar to a vaginal yeast infection (vaginal discharge, irritation and itching), their diagnosis must be made by a doctor so that proper treatment can be given.

If these infections are not properly treated or if proper treatment is delayed, serious problems, such as pelvic inflammatory disease (PID) may result, which may prevent you from having children in the future. If you are pregnant and do not get the proper treatment, the infection may be passed to your baby before or during delivery and may cause your baby to have permanent damage. If you have multiple sex partners or a new sex partner, you should also ask a doctor before use to make sure you do not have an STD.

Why do women get repeated vaginal yeast infections?

Women may get repeated vaginal yeast infections that may not clear up easily with proper treatment. Listed below are some of the causes of repeated yeast infections:

  • hormonal changes occurring a few days before the monthly period
  • use of antibiotics
  • use of some birth control pills
  • pregnancy
  • diabetes ("sugar" or "high blood sugar")
  • clothing - wearing tight layers or moist clothing in the genital area
  • weakened immune system - some drugs (such as chemotherapy or steroids) and medical conditions can weaken the body's normal ability to fight infection. One of the most serious of these conditions is infection with the human immunodeficiency virus (HIV - the virus that causes AIDS). Infection with HIV causes the person to be more likely to get infections, including vaginal yeast infections.

If you get vaginal yeast infections often (such as once a month or 3 in 6 months), you should talk to a doctor.

Are vaginal yeast infections sexually transmitted?

Vaginal yeast infections are usually not spread by having intercourse (sex). However, if your partner has a rash, itching or discomfort in his genital area, he should contact a doctor to find out the cause of his symptoms and tell the doctor that you are treating your vaginal yeast infection with this product.

How can I prevent repeated vaginal yeast infections?

To lower your chances of getting another yeast infection:

• Try to keep the genital area cool and dry. Yeast grow well in warm, moist areas. The following suggestions may be helpful:

(1) Wear cotton underwear and loose-fitting clothes.

(2) Change out of damp clothes or a wet bathing suit as soon as possible.

(3) If you use minipads when you are not having a menstrual period, change the minipads often.

• Talk with your doctor about any drugs you are now taking. You are more likely to get a vaginal yeast infection if you are taking certain drugs such as antibiotics, steroids, or birth control pills. Do not stop taking these drugs without first asking your doctor. A doctor may need to see you to make sure that you do not have other medical conditions such as diabetes or a weakened immune system.

Can I use this product during my menstrual period?

Yes, this product can be used during your menstrual period. In fact, many women get vaginal yeast infections just before their period because of hormonal changes. Using this product during your period will not affect how well this product works. If you have started treatment and your period occurs, you should complete the full course of treatment.

Do not use tampons while using this product, because tampons may remove some of the drug from the vagina. Use deodorant-free sanitary napkins or pads instead, and change them often.

Can I use other vaginal products with this product?

This drug should not be used with other vaginal products.

  • Douches and tampons may remove some of the cream from the vagina.
  • Spermicides may interfere with this product.
  • Condoms and diaphragms may be damaged by this product and fail to prevent pregnancy or sexually transmitted diseases (STDs).

How can I get the best results when treating my infection?

  • Use 1 cream prefilled applicator at bedtime, even during your menstrual period for 3 nights in a row.
  • Use the tube of cream externally only while symptoms are present. If you have symptoms (such as itching and irritation) on the skin outside the vagina (vulva), apply the cream externally 2 times a day, up to a total of 7 days, as needed.
  • Dry the genital area thoroughly after a shower, bath or swim. Change out of a wet bathing suit or damp clothes as soon as possible. A dry area is less likely to lead to the overgrowth of yeast.
  • Wear cotton underwear and loose-fitting clothes.
  • Wipe from front to back after a bowel movement or after urination.
  • Do not douche, because douching may wash the drug out of the vagina.
  • Do not use tampons, because they remove some of the drug from the vagina. Use deodorant-free sanitary napkins or pads as needed.
  • Do not use spermicides, as they may interfere with this product.
  • Do not have vaginal intercourse while using this product.
  • Do not scratch the skin outside the vagina. Scratching can cause more irritation and can spread the infection.
  • Tell your doctor about any drugs you are now taking. Certain drugs such as antibiotics, steroids, and birth control pills, may make it more likely for you to get a vaginal yeast infection. If you are taking any of these drugs do not stop taking them without first asking a doctor.
  • If you have any other medical questions or concerns about vaginal yeast infections, call your doctor.

What warnings should I know about when using this product?

For vaginal use only.

Do not use if you have never had a vaginal yeast infection diagnosed by a doctor.

Ask a doctor before use if you have:

  • vaginal itching and discomfort for the first time. You may need a different treatment.
  • lower abdominal, back or shoulder pain, fever, chills, nausea, vomiting, or foul-smelling vaginal discharge. You could have a more serious condition.
  • vaginal yeast infections often (such as once a month or 3 in 6 months). You could be pregnant or have a serious underlying medical cause for your symptoms, including diabetes or a weakened immune system.
  • been exposed to the human immunodeficiency virus (HIV) that causes AIDS.

Ask a doctor or pharmacist before use if you are taking the prescription blood thinning medicine, warfarin (coumadin), because bleeding or bruising may occur.

When using this product:

  • do not use tampons, douches, spermicides, or other vaginal products. Condoms and diaphragms may be damaged and fail to prevent pregnancy or sexually transmitted diseases (STDs).
  • do not have vaginal intercourse
  • mild increase in vaginal burning, itching or irritation may occur
  • if you do not get complete relief ask a doctor before using another product

How Should I Use This Product?

This product is for adults and children 12 years of age and over. For children under 12 years, ask a doctor.

Directions for using the Applicator containing the Vaginal Cream:

Begin treatment before going to bed:

1 Remove the prefilled applicator from the wrapper.

2 Unscrew and remove violet cap from prefilled applicator.

3 Insert plunger into prefilled applicator by placing small end of plunger into the ribbed end of the applicator.

Image 1
Image 1

4 Gently insert the applicator into the vagina as far as it will go comfortably. This can be done while lying on your back with your knees bent (as shown in the picture) or while standing with your feet apart and your knees bent.

Image 2
Image 2

5 With one hand holding the barrel, use the other hand to push the plunger all the way in to place the cream as far back in the vagina as possible. Then remove both parts of the applicator from the vagina.

6 Throw the applicator away after use. Do not flush in toilet.

7 Lie down as soon as possible after inserting the cream. This will reduce leakage.

8 Repeat steps 1 through 7 before going to bed for the next 2 days.

You may want to use deodorant-free pads or pantyshields to protect your clothing during the time that you are using this product. This is because the cream can leak or you may get some discharge. Do not use tampons, douches, spermicides, condoms or diaphragms until after you have completed treatment and your symptoms are gone.

Directions for using the External Vulvar Cream

Use the cream twice daily, for up to 7 days as needed.

1. Open the tube by unscrewing the cap. The first time the tube is opened, press the sharp point of the cap into the sealed end of the tube. Push down firmly until the seal is open.

Image 3
Image 3
Image 4
Image 4

2. Squeeze a small amount of cream onto your fingertip.

3. Apply the cream onto the skin outside the vagina (vulva) that itches and is irritated.

4. Screw the cap back on the tube.

5. Repeat steps 2-4 each morning and at bedtime for up to 7 days, as needed.

Stop use and ask your doctor if:

  • symptoms do not get better in 3 days
  • symptoms last more than 7 days
  • you get a rash or hives, abdominal pain, fever, chills, nausea, vomiting, or foul-smelling vaginal discharge.

These may be signs that this product is not working, or you may have a more serious condition or an allergic reaction.

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away (1-800-222-1222).

What side effects may occur with this product?

A mild increase in vaginal burning, itching, or irritation may occur when the applicator containing the cream is inserted. Abdominal cramping has also been reported.

Stop using this product and consult your doctor if you have abdominal pain, hives, skin rash, or if you have severe vaginal burning, itching, or irritation or swelling.

What should I do if I have questions about this product?

If you have questions of a medical nature, please contact your pharmacist, doctor or health care professional. If you have any other questions or need more information on this product, call our toll-free number 1-800-719-9260.

Other Information:

  • TAMPER-EVIDENT UNIT – do not use if printed applicator wrapper is torn, open or incompletely sealed.
  • do not use if tube seal has been punctured.
  • store at 20°-25°C (68°-77°F)

Active Ingredients: Prefilled Applicators: miconazole nitrate 4% (200 mg per applicator) External Vulvar Cream: miconazole nitrate 2%

Inactive Ingredients: Prefilled Applicators: benzoic acid, cetyl alcohol, isopropyl myristate, polysorbate 60, potassium hydroxide, propylene glycol, purified water, stearyl alcohol. External Vulvar Cream: benzoic acid, butylated hydroxyanisole, glyceryl stearate, mineral oil, peglicol 5 oleate, pegoxol 7 stearate, purified water.

Distributed By

Perrigo®

Allegan, MI 49010

02/16

: 98200 00 J4

Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

3 Ready-to-Use Prefilled Applicators

Cream for External Relief

Compare to Monistat® 3 active ingredients

Miconazole

MICONAZOLE NITRATE VAGINAL CREAM (4%) & MICONAZOLE NITRATE CREAM (2%)

VAGINAL ANTIFUNGAL | COMBINATION PACK

3-DAY TREATMENT

CURES most vaginal YEAST INFECTIONS & relieves associated external itching & irritation

3 PREFILLED APPLICATORS PLUS EXTERNAL CREAM

(MICONAZOLE NITRATE 200 mg PER APPLICATOR PLUS 2% EXTERNAL VULVAR CREAM)

NET WT 0.18 OZ (5 g) EACH APPLICATOR AND 0.32 OZ (9 g) TUBE

Miconazole 3 Carton Image 1
Miconazole 3 Carton Image 1
Miconazole 3 Carton Image 2
Miconazole 3 Carton Image 2

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0363-0637-00EA - Each0363-06375f805db2-eb38-4443-b13e-cd0b058a4f2412022-06-06

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
MICONAZOLE NITRATEACTIVE INGREDIENTVW4H1CYW1K2
MICONAZOLEACTIVE MOIETY7NNO0D7S5M2
BENZOIC ACIDINACTIVE INGREDIENT8SKN0B0MIM2
BUTYLATED HYDROXYANISOLEINACTIVE INGREDIENTREK4960K2U2
CETYL ALCOHOLINACTIVE INGREDIENT936JST6JCN2
GLYCERYL MONOSTEARATEINACTIVE INGREDIENT230OU9XXE42
ISOPROPYL MYRISTATEINACTIVE INGREDIENT0RE8K4LNJS2
MINERAL OILINACTIVE INGREDIENTT5L8T28FGP2
PEG-5 OLEATEINACTIVE INGREDIENT0240V77G502
PEGOXOL 7 STEARATEINACTIVE INGREDIENT3EW5AXE5X52
POLYSORBATE 60INACTIVE INGREDIENTCAL22UVI4M2
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4T2
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V32
STEARYL ALCOHOLINACTIVE INGREDIENT2KR89I4H1Y2
WATERINACTIVE INGREDIENT059QF0KO0R2

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 16 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
0363-06370363-0637-00

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 17 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 5 · 264 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
POTASSIUM HYDROXIDEPOTASSIUM HYDROXIDEWZH3C48M4TAEROSOL, FOAM / TOPICALADJ PHExact identifier — unii candidate
13 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPCAPSULE, EXTENDED RELEASE / ORAL120 mgExact identifier — unii candidate
30 equally ranked IID candidates
STEARYL ALCOHOLSTEARYL ALCOHOL2KR89I4H1YCAPSULE, EXTENDED RELEASE / ORAL72 mgExact identifier — unii candidate
12 equally ranked IID candidates
BUTYLATED HYDROXYANISOLEBUTYLATED HYDROXYANISOLEREK4960K2UTABLET, ORALLY DISINTEGRATING / ORAL2 mgExact identifier — unii candidate
24 equally ranked IID candidates
BUTYLATED HYDROXYANISOLEBUTYLATED HYDROXYANISOLEREK4960K2UOINTMENT / TOPICAL0.01 %w/wExact identifier — unii candidate
24 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPGEL / TOPICAL2.5 %w/wExact identifier — unii candidate
30 equally ranked IID candidates
CETYL ALCOHOLCETYL ALCOHOL936JST6JCNOINTMENT / TOPICAL7 %w/wExact identifier — unii candidate
20 equally ranked IID candidates
BENZOIC ACIDBENZOIC ACID8SKN0B0MIMSUSPENSION / ORAL15 mgExact identifier — unii candidate
23 equally ranked IID candidates
POTASSIUM HYDROXIDEPOTASSIUM HYDROXIDEWZH3C48M4TCAPSULE / ORAL172 mgExact identifier — unii candidate
13 equally ranked IID candidates
GLYCERYL MONOSTEARATEGLYCERYL MONOSTEARATE230OU9XXE4CREAM / VAGINAL140 mgExact identifier — unii candidate
21 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3CAPSULE / ORAL1072 mgExact identifier — unii candidate
81 equally ranked IID candidates
BUTYLATED HYDROXYANISOLEBUTYLATED HYDROXYANISOLEREK4960K2UCONCENTRATE / ORAL0.08 mg/1mlExact identifier — unii candidate
24 equally ranked IID candidates
POLYSORBATE 60POLYSORBATE 60CAL22UVI4MCREAM / VAGINAL200 mgExact identifier — unii candidate
13 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SOLUTION / ORAL22602 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SOLUTION / DENTAL2 %w/wExact identifier — unii candidate
81 equally ranked IID candidates
GLYCERYL MONOSTEARATEGLYCERYL MONOSTEARATE230OU9XXE4CAPSULE, EXTENDED RELEASE / ORAL32.4 mgExact identifier — unii candidate
21 equally ranked IID candidates
BENZOIC ACIDBENZOIC ACID8SKN0B0MIMAEROSOL, FOAM / VAGINAL0.1 %w/wExact identifier — unii candidate
23 equally ranked IID candidates
POLYSORBATE 60POLYSORBATE 60CAL22UVI4MEMULSION / ORAL20 mg/1mlExact identifier — unii candidate
13 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SUSPENSION / OPHTHALMIC0.6 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
POTASSIUM HYDROXIDEPOTASSIUM HYDROXIDEWZH3C48M4TCREAM / TOPICAL0.5 %w/wExact identifier — unii candidate
13 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3TABLET, FILM COATED / ORAL96 mgExact identifier — unii candidate
81 equally ranked IID candidates
BUTYLATED HYDROXYANISOLEBUTYLATED HYDROXYANISOLEREK4960K2UTABLET, EXTENDED RELEASE / ORAL1 mgExact identifier — unii candidate
24 equally ranked IID candidates
BUTYLATED HYDROXYANISOLEBUTYLATED HYDROXYANISOLEREK4960K2UINJECTION, SOLUTION / INTRAVENOUSNAExact identifier — unii candidate
24 equally ranked IID candidates
POTASSIUM HYDROXIDEPOTASSIUM HYDROXIDEWZH3C48M4TSOLUTION / TOPICAL14.02 %w/wExact identifier — unii candidate
13 equally ranked IID candidates
PEG-5 OLEATEPEG-5 OLEATE0240V77G50CREAM / TOPICAL98 mgExact identifier — unii candidate
5 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3INJECTION / INTRAVENOUS16624 mgExact identifier — unii candidate
81 equally ranked IID candidates
BENZOIC ACIDBENZOIC ACID8SKN0B0MIMELIXIR / ORAL90 mgExact identifier — unii candidate
23 equally ranked IID candidates
CETYL ALCOHOLCETYL ALCOHOL936JST6JCNSUSPENSION / OPHTHALMIC0.5 %w/vExact identifier — unii candidate
20 equally ranked IID candidates
BUTYLATED HYDROXYANISOLEBUTYLATED HYDROXYANISOLEREK4960K2UINJECTION / INTRAVENOUSNAExact identifier — unii candidate
24 equally ranked IID candidates
BENZOIC ACIDBENZOIC ACID8SKN0B0MIMLOTION / TOPICAL0.2 %w/wExact identifier — unii candidate
23 equally ranked IID candidates
BUTYLATED HYDROXYANISOLEBUTYLATED HYDROXYANISOLEREK4960K2USUPPOSITORY / RECTAL1 mgExact identifier — unii candidate
24 equally ranked IID candidates
POTASSIUM HYDROXIDEPOTASSIUM HYDROXIDEWZH3C48M4TCREAM / VAGINAL3 mgExact identifier — unii candidate
13 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3GEL / TOPICAL4522 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3DROPS / ORAL200 mg/1mlExact identifier — unii candidate
81 equally ranked IID candidates
BUTYLATED HYDROXYANISOLEBUTYLATED HYDROXYANISOLEREK4960K2USUSPENSION / ORAL2.5 mg/5mlExact identifier — unii candidate
24 equally ranked IID candidates
BUTYLATED HYDROXYANISOLEBUTYLATED HYDROXYANISOLEREK4960K2UOINTMENT / VAGINAL0.02 %w/wExact identifier — unii candidate
24 equally ranked IID candidates
CETYL ALCOHOLCETYL ALCOHOL936JST6JCNTABLET, FILM COATED, EXTENDED RELEASE / ORAL59 mgExact identifier — unii candidate
20 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPPASTE / TOPICAL47.5 %w/wExact identifier — unii candidate
30 equally ranked IID candidates
BUTYLATED HYDROXYANISOLEBUTYLATED HYDROXYANISOLEREK4960K2ULOTION / TOPICALNAExact identifier — unii candidate
24 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3INJECTION / SUBCUTANEOUS1.4 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3EMULSION / OPHTHALMIC1.5 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
POLYSORBATE 60POLYSORBATE 60CAL22UVI4MSUPPOSITORY / VAGINAL0.03 mgExact identifier — unii candidate
13 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPSUPPOSITORY / RECTALNAExact identifier — unii candidate
30 equally ranked IID candidates
POLYSORBATE 60POLYSORBATE 60CAL22UVI4MSUSPENSION / TOPICAL2.85 %w/wExact identifier — unii candidate
13 equally ranked IID candidates
BENZOIC ACIDBENZOIC ACID8SKN0B0MIMSOLUTION / ORAL100 mgExact identifier — unii candidate
23 equally ranked IID candidates
BUTYLATED HYDROXYANISOLEBUTYLATED HYDROXYANISOLEREK4960K2UTABLET / ORAL8 mgExact identifier — unii candidate
24 equally ranked IID candidates
CETYL ALCOHOLCETYL ALCOHOL936JST6JCNSOLUTION / TOPICALNAExact identifier — unii candidate
20 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SOLUTION, CONCENTRATE / INTRAVENOUS50.33 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SUSPENSION / ORAL27120 mgExact identifier — unii candidate
81 equally ranked IID candidates
GLYCERYL MONOSTEARATEGLYCERYL MONOSTEARATE230OU9XXE4GRANULE, FOR SUSPENSION / ORAL4 mgExact identifier — unii candidate
21 equally ranked IID candidates
GLYCERYL MONOSTEARATEGLYCERYL MONOSTEARATE230OU9XXE4SUSPENSION / OPHTHALMIC0.5 %w/vExact identifier — unii candidate
21 equally ranked IID candidates
STEARYL ALCOHOLSTEARYL ALCOHOL2KR89I4H1YSUPPOSITORY / VAGINAL8.5 mgExact identifier — unii candidate
12 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPCAPSULE / ORAL120 mgExact identifier — unii candidate
30 equally ranked IID candidates
PEG-5 OLEATEPEG-5 OLEATE0240V77G50SOLUTION / ORAL1600 mgExact identifier — unii candidate
5 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPOINTMENT / AURICULAR (OTIC)NAExact identifier — unii candidate
30 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SOLUTION / RESPIRATORY (INHALATION)25 %w/wExact identifier — unii candidate
81 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPSUSPENSION / OPHTHALMIC0.1 %w/wExact identifier — unii candidate
30 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPTABLET, COATED / ORAL1.5 mgExact identifier — unii candidate
30 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3AEROSOL, FOAM / VAGINAL6.4 %w/wExact identifier — unii candidate
81 equally ranked IID candidates
STEARYL ALCOHOLSTEARYL ALCOHOL2KR89I4H1YTABLET / ORAL20 mgExact identifier — unii candidate
12 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A076357-001MICONAZOLE 3 COMBINATION PACKMICONAZOLE NITRATE2%,4%CREAM / TOPICAL, VAGINAL2004-03-30

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A076357-001MICONAZOLE 3 COMBINATION PACK2%,4%CREAM / TOPICAL, VAGINAL2004-03-3084e616aacf4f…
2026-08-18 06:07:402026-07A076357-001MICONAZOLE 3 COMBINATION PACK2%,4%CREAM / TOPICAL, VAGINAL2004-03-30caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A076357-001MICONAZOLE 3 COMBINATION PACK2%,4%CREAM / TOPICAL, VAGINAL2004-03-30011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A076357-001MICONAZOLE 3 COMBINATION PACK2%,4%CREAM / TOPICAL, VAGINAL2004-03-3031067a03dcf5…
2025-08-23 18:47 UTC2025-08A076357-001MICONAZOLE 3 COMBINATION PACK2%,4%CREAM / TOPICAL, VAGINAL2004-03-306a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A076357-001MICONAZOLE 3 COMBINATION PACK2%,4%CREAM / TOPICAL, VAGINAL2004-03-30fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A076357-001MICONAZOLE 3 COMBINATION PACK2%,4%CREAM / TOPICAL, VAGINAL2004-03-30b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A076357-001MICONAZOLE 3 COMBINATION PACK2%,4%CREAM / TOPICAL, VAGINAL2004-03-3003ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A076357-001MICONAZOLE 3 COMBINATION PACK2%,4%CREAM / TOPICAL, VAGINAL2004-03-302680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A076357-001MICONAZOLE 3 COMBINATION PACK2%,4%CREAM / TOPICAL, VAGINAL2004-03-305bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A076357-001MICONAZOLE 3 COMBINATION PACK2%,4%CREAM / TOPICAL, VAGINAL2004-03-30d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A076357-001MICONAZOLE 3 COMBINATION PACK2%,4%CREAM / TOPICAL, VAGINAL2004-03-30d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A076357-001MICONAZOLE 3 COMBINATION PACK2%,4%CREAM / TOPICAL, VAGINAL2004-03-3079d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A076357-001MICONAZOLE 3 COMBINATION PACK2%,4%CREAM / TOPICAL, VAGINAL2004-03-30301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A076357-001MICONAZOLE 3 COMBINATION PACK2%,4%CREAM / TOPICAL, VAGINAL2004-03-301e350fbaab3a…
2024-05-31 18:47 UTC2024-05A076357-001MICONAZOLE 3 COMBINATION PACK2%,4%CREAM / TOPICAL, VAGINAL2004-03-308072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A076357-001MICONAZOLE 3 COMBINATION PACK2%,4%CREAM / TOPICAL, VAGINAL2004-03-305c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A076357-001MICONAZOLE 3 COMBINATION PACK2%,4%CREAM / TOPICAL, VAGINAL2004-03-305d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A076357-001MICONAZOLE 3 COMBINATION PACK2%,4%CREAM / TOPICAL, VAGINAL2004-03-304b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A076357-001MICONAZOLE 3 COMBINATION PACK2%,4%CREAM / TOPICAL, VAGINAL2004-03-3074a2ff9319b5…
2022-03-09 01:35 UTC2022-03A076357-001MICONAZOLE 3 COMBINATION PACK2%,4%CREAM / TOPICAL, VAGINAL2004-03-30bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A076357-001MICONAZOLE 3 COMBINATION PACK2%,4%CREAM / TOPICAL, VAGINAL2004-03-30782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A076357-001MICONAZOLE 3 COMBINATION PACK2%,4%CREAM / TOPICAL, VAGINAL2004-03-3087673890dc5c…
2021-03-12 10:30 UTC2021-03A076357-001MICONAZOLE 3 COMBINATION PACK2%,4%CREAM / TOPICAL, VAGINAL2004-03-305aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A076357-001MICONAZOLE 3 COMBINATION PACK2%,4%CREAM / TOPICAL, VAGINAL2004-03-308869cabd3fbd…
2020-11-12 02:37 UTC2020-11A076357-001MICONAZOLE 3 COMBINATION PACK2%,4%CREAM / TOPICAL, VAGINAL2004-03-30c0c555d07b60…
2019-12-14 00:12 UTC2019-12A076357-001MICONAZOLE 3 COMBINATION PACK2%,4%CREAM / TOPICAL, VAGINAL2004-03-303f01610625f2…
2019-09-15 20:21 UTC2019-09A076357-001MICONAZOLE 3 COMBINATION PACK2%,4%CREAM / TOPICAL, VAGINAL2004-03-30b00525d2431f…
2019-07-19 19:46 UTC2019-07A076357-001MICONAZOLE 3 COMBINATION PACK2%,4%CREAM / TOPICAL, VAGINAL2004-03-30ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A076357-001MICONAZOLE 3 COMBINATION PACK2%,4%CREAM / TOPICAL, VAGINAL2004-03-306a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A076357-001MICONAZOLE 3 COMBINATION PACK2%,4%CREAM / TOPICAL, VAGINAL2004-03-301c564ffb4f44…
2023-12-20 04:57 UTC2023-12A076357-001MICONAZOLE 3 COMBINATION PACK2%,4%CREAM / TOPICAL, VAGINAL2004-03-30ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A076357-001MICONAZOLE 3 COMBINATION PACK2%,4%CREAM / TOPICAL, VAGINAL2004-03-30a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A076357-001MICONAZOLE 3 COMBINATION PACK2%,4%CREAM / TOPICAL, VAGINAL2004-03-309b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A076357-001MICONAZOLE 3 COMBINATION PACK2%,4%CREAM / TOPICAL, VAGINAL2004-03-30a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A076357-001MICONAZOLE 3 COMBINATION PACK2%,4%CREAM / TOPICAL, VAGINAL2004-03-303f0d92c62455…
2023-05-13 08:27 UTC2023-05A076357-001MICONAZOLE 3 COMBINATION PACK2%,4%CREAM / TOPICAL, VAGINAL2004-03-30053a50430f4f…
2023-01-26 05:58 UTC2023-01A076357-001MICONAZOLE 3 COMBINATION PACK2%,4%CREAM / TOPICAL, VAGINAL2004-03-303bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A076357-001MICONAZOLE 3 COMBINATION PACK2%,4%CREAM / TOPICAL, VAGINAL2004-03-303a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A076357-001MICONAZOLE 3 COMBINATION PACK2%,4%CREAM / TOPICAL, VAGINAL2004-03-30f41ea6bd6efb…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
22a8a45a-9e92-4ca3-a4c9-909753d9a47eaacb0b61-e899-4e84-826b-c696acaf52352023-09-05WarningsExact identifier
spl set id: aacb0b61-e899-4e84-826b-c696acaf5235

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.